(0/) 2024-12-07 13:31:54
(0/) 2024-12-07 13:01:34
科学篇之十二(第1节): 抗原呈递(Antigen Presentation)
(0/) 2024-12-07 12:33:43
(0/) 2024-12-05 15:07:56
(0/) 2024-12-05 14:17:48
(18/) 2024-11-26 19:24:28
工程篇之十一(第2节): IBI363 (PD-1/IL-2α-bias)
(0/) 2024-11-23 16:58:15
工程篇之十一(第1节): 偏向型IL-2(Biased IL-2)
(0/) 2024-11-23 16:07:47
(0/) 2024-11-23 12:04:34
科学篇之十一(第2节): 白细胞介素(Interleukin)
(0/) 2024-11-23 11:52:08
(0/) 2024-11-23 11:46:08
经济篇之十一(第1节): 小罗伯特·肯尼迪(Robert F. Kennedy Jr.,RFK)和FDA可能的变革
(0/) 2024-11-20 18:59:42
(0/) 2024-11-13 08:23:11
(1/) 2024-11-03 05:03:01
(0/) 2024-11-02 19:46:18
(1/) 2024-11-02 19:27:27
(6/) 2024-11-02 19:19:47
阿拉斯加的排序投票(Ranked-Choice Voting, RCV)系统
(0/) 2024-11-01 12:22:26
(0/) 2024-11-01 12:18:47
(0/) 2024-11-01 11:49:32
(0/) 2024-10-31 08:03:27
Ted Kaczynski (the 'Unabomber”) and the Manifesto (工业社会及其未来)
(0/) 2024-10-31 07:25:26
(0/) 2024-10-30 17:21:24
工程篇之十: 生物药“车间” - 中国仓鼠卵巢(CHO)细胞
(0/) 2024-10-30 07:03:23
(0/) 2024-10-07 11:42:50
经济篇之九(第1节): FDA和PDUFA(Prescription Drug User Fee Act)
(0/) 2024-09-22 10:32:26
(0/) 2024-09-08 17:51:05
工程篇之九(第2节): 双抗技术平台-DuoBody技术简介
(0/) 2024-09-08 07:32:18
(2/) 2024-08-19 18:24:56
科学篇之九(第1节): T细胞连接器(T Cell Engager, TCE)
(0/) 2024-08-19 14:45:41
工程篇之九(第1节): 双特异抗体(Bispecific Antibodies, BsAbs)
(0/) 2024-08-14 14:48:29
(0/) 2024-08-11 07:08:31
(0/) 2024-08-08 14:50:04
(0/) 2024-08-04 09:55:01
(0/) 2024-07-22 08:52:26
(0/) 2024-07-22 08:26:10
(0/) 2024-07-21 18:35:36
(0/) 2024-07-21 14:55:36
(0/) 2024-07-07 08:59:10
(0/) 2024-06-29 21:47:12
(0/) 2024-06-29 21:08:05
(1/) 2024-06-27 14:50:43
(0/) 2024-06-18 08:01:56
(1/) 2024-06-17 14:44:56
(0/) 2024-06-08 09:40:48
(0/) 2024-06-04 20:24:18
(0/) 2024-06-04 20:18:44
(0/) 2024-06-04 20:08:28
(0/) 2024-05-22 11:52:14
(0/) 2024-05-15 12:06:55
(0/) 2024-04-28 09:19:58
科学篇之四(第2节): 抗体偶联药物(Antibody-Drug Conjugates,ADC)
(0/) 2024-04-26 19:36:51
(7/) 2024-04-24 15:39:51
经济篇之N(第5节): The Inflation Reduction Act (IRA) of 2022 and Drug
(0/) 2024-04-19 17:26:30
经济篇之N(第四节): Government Pricing Calculations
(0/) 2024-04-18 18:57:57
经济篇之N(第三节): Government Pricing Regulations in the U.S. Pharmaceu
(0/) 2024-04-09 12:11:33
经济篇之N(第二节): Revenue recognition and gross-to-net (GTN) adjustmen
(0/) 2024-04-07 11:40:09
(0/) 2024-04-03 14:58:58
(6/) 2024-03-25 20:02:48
经济篇之三(第一节): “药王” - 当代 “和氏璧”的故事
(0/) 2024-03-22 13:57:22